Skip to main content
. Author manuscript; available in PMC: 2024 Mar 28.
Published in final edited form as: Womens Health Issues. 2022 Dec 1;33(2):133–141. doi: 10.1016/j.whi.2022.10.002

Table 2.

Odds of Using Contraceptive Method Categories Compared With No Method, Pregnancy Risks Assessment Monitoring System Respondents in 20 Jurisdictions,* 2018

Variable Contraceptive Method (Ref: None) Adjusted Odds Ratio Estimates (95% Confidence Interval)

Insurance (ref: private)
 Public Permanent 1.07 (0.87–1.31)
LARC 0.91 (0.76–1.09)
SARC 0.91 (0.77–1.07)
Less effective 0.67 (0.56–0.79)
 No insurance Permanent 0.72 (0.53–0.98)
LARC 0.67 (0.51–0.89)
SARC 0.61 (0.47–0.81)
Less effective 0.93 (0.72–1.21)
Geographic setting (ref: urban)
 Rural Permanent 2.15 (1.67–2.77)
LARC 1.31 (1.04–1.65)
SARC 1.42 (1.15–1.76)
Less effective 1.38 (1.11–1.72)

Abbreviations: LARC, long-acting reversible contraception, including intrauterine devices and contraceptive implants; SARC, short-acting reversible contraception, including contraceptive pills, patches, rings, and injections.

*

Jurisdictions included were Alaska, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Maine, Michigan, Missouri, New Jersey, New Mexico, Pennsylvania, Utah, Virginia, Washington, Wisconsin, West Virginia, Wyoming, and New York City.

Insurance coverage at the time the respondent completed the Pregnancy Risks Assessment Monitoring System survey.

Adjusted model includes insurance type, geographic setting, maternal age, race/ethnicity, and parity.